Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Thurgur

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Review of Neurobiology|June 20, 2025
PrefaceDavid John Nutt, Hannah Thurgur
Neuroscience|April 23, 2019
Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System DisordersHannah Thurgur, Emmanuel Pinteaux
Journal of Neuroimmunology|November 3, 2022
Endothelial cell activation by interleukin-1 and extracellular matrix laminin-10 occurs via the YAP signalling pathwayHannah Thurgur, Jeffrey Penny, Emmanuel Pinteaux
Drugs & Aging|June 16, 2024
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Frontiers in Psychology|May 30, 2023
ARC: a framework for access, reciprocity and conduct in psychedelic therapiesMeg J Spriggs, Ashleigh Murphy-Beiner, Roberta Murphy, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 10, 2025
MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-upHannah Thurgur, Ben Sessa, Laurie Higbed, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Review of Neurobiology|June 20, 2025
PrefaceDavid John Nutt, Hannah Thurgur
Neuroscience|April 23, 2019
Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System DisordersHannah Thurgur, Emmanuel Pinteaux
Journal of Neuroimmunology|November 3, 2022
Endothelial cell activation by interleukin-1 and extracellular matrix laminin-10 occurs via the YAP signalling pathwayHannah Thurgur, Jeffrey Penny, Emmanuel Pinteaux
Drugs & Aging|June 16, 2024
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Frontiers in Psychology|May 30, 2023
ARC: a framework for access, reciprocity and conduct in psychedelic therapiesMeg J Spriggs, Ashleigh Murphy-Beiner, Roberta Murphy, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 10, 2025
MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-upHannah Thurgur, Ben Sessa, Laurie Higbed, et al.
Pageof 1